Violation Tracker Individual Record

Company: 
GlaxoSmithKline
Current Parent Company: 
GlaxoSmithKline
Penalty: 
$477,792,391
Year: 
2012
Date: 
July 2, 2012
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Violation Description: 

GlaxoSmithKline paid $477.8 million to settle multistate allegations relating to: the unlawful marketing of certain drugs for uses for which they were not approved by the Food and Drug Administration; making false representations regarding the safety and efficacy of certain drugs; offering kickbacks to medical professionals; and underpaying rebates owed to government programs for various drugs paid for by Medicaid and other federally-funded healthcare programs. This was part of a larger $3 billion civil and criminal settlement that involved the FDA and the Justice Department; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-glaxosmith...

Level of Government: 
state
Action Type: 
agency action
Agency: 
Multistate Attorneys General Case
Civil or Criminal Case: 
civil
HQ Country of Parent: 
United Kingdom
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.